These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2360816)

  • 1. Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis.
    Rastogi N; Goh KS; David HL
    Antimicrob Agents Chemother; 1990 May; 34(5):759-64. PubMed ID: 2360816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine as methyl-group donor in the synthesis of Mycobacterium avium envelope lipids, and its inhibition by DL-ethionine, D-norleucine and DL-norleucine.
    David HL; Clavel-Seres S; Clément F; Lazlo A; Rastogi N
    Acta Leprol; 1989; 7 Suppl 1():77-80. PubMed ID: 2504011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.
    Rastogi N; Labrousse V
    Antimicrob Agents Chemother; 1991 Mar; 35(3):462-70. PubMed ID: 1828135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of 1-isonicotinyl-2-palmitoyl hydrazine against the Mycobacterium avium complex and enhancement of its activity by m-fluorophenylalanine.
    Rastogi N; Goh KS
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2061-4. PubMed ID: 2073098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of subinhibitory concentrations of dapsone alone and in combination with cell-wall inhibitors against Mycobacterium avium complex organisms.
    Rastogi N; Goh KS; Labrousse V
    Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):954-8. PubMed ID: 8187794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the cell envelope of Mycobacterium avium.
    David HL; Rastogi N; Clavel-Sérès S; Clément F; Thorel MF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):49-66. PubMed ID: 3630478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?
    Rastogi N; Frehel C; Ryter A; Ohayon H; Lesourd M; David HL
    Antimicrob Agents Chemother; 1981 Nov; 20(5):666-77. PubMed ID: 6798925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in drug susceptibility distribution and clinical characteristics between
    Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
    [No Abstract]   [Full Text] [Related]  

  • 10. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol.
    Belanger AE; Besra GS; Ford ME; Mikusová K; Belisle JT; Brennan PJ; Inamine JM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11919-24. PubMed ID: 8876238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.
    Barrow WW; Wright EL; Goh KS; Rastogi N
    Antimicrob Agents Chemother; 1993 Apr; 37(4):652-61. PubMed ID: 8494359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
    Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis.
    Heifets L; Lindholm-Levy P
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1298-301. PubMed ID: 2478073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Susceptibility and Genotyping of Mycobacterium avium Strains That Cause Pulmonary and Disseminated Infection.
    Uchiya KI; Asahi S; Futamura K; Hamaura H; Nakagawa T; Nikai T; Ogawa K
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378709
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium.
    Deshpande D; Srivastava S; Meek C; Leff R; Gumbo T
    Antimicrob Agents Chemother; 2010 May; 54(5):1728-33. PubMed ID: 20231389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques.
    Rastogi N; Goh KS; Wright EL; Barrow WW
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2287-95. PubMed ID: 7840559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of in vitro susceptibility of mycobacteria to ansamycin.
    Heifets LB; Iseman MD
    Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stazyme, a mycobacteriolytic preparation from a Staphylococcus strain, is able to break the permeability barrier in multiple drug resistant Mycobacterium avium.
    Rastogi N; Goh KS; Clavel-Sérès S
    FEMS Immunol Med Microbiol; 1997 Dec; 19(4):297-305. PubMed ID: 9537755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.